Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chain
Thirumalai R. Ramalingam(National Institutes of Health), Thomas A. Wynn(National Institute of Allergy and Infectious Diseases), John Pesce(National Institute of Allergy and Infectious Diseases), Joseph F. Urban(Beltsville Human Nutrition Research Center), Mark S. Wilson(Gene Therapy Laboratory), Faruk Sheikh(United States Food and Drug Administration), Raymond P. Donnelly(Center for Biologics Evaluation and Research), George D. Yancopoulos(Regeneron (United States)), Andrew Murphy(DePaul University), Sean Stevens(Regeneron (United States)), Allen W. Cheever(Biomedical Research Institute), David M. Valenzuela(Regeneron (United States)), Margaret Mentink‐Kane(National Institutes of Health)
Cited by 182
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
|New England Journal of Medicine|2020|1.8k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k